Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet 2017 Jul 26. pii: S0140-6736(17)31613.
PMID: 28755782


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016